CYP — Cynata Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- AU$33.23m
- AU$22.06m
- AU$0.35m
Annual balance sheet for Cynata Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 6.98 | 13.7 | 26.7 | 23.8 | 16.2 |
| Net Total Receivables | 0.063 | 0.013 | 0.253 | 0.075 | 0.342 |
| Prepaid Expenses | |||||
| Total Current Assets | 7.33 | 13.9 | 27.3 | 24.1 | 16.9 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 12.2 | 17.5 | 30 | 26.5 | 19 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 1.28 | 0.69 | 1.6 | 2.59 | 2.26 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 1.28 | 0.69 | 1.6 | 2.59 | 2.26 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 11 | 16.8 | 28.4 | 24 | 16.7 |
| Total Liabilities & Shareholders' Equity | 12.2 | 17.5 | 30 | 26.5 | 19 |
| Total Common Shares Outstanding |